Review paper<br>Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes?

Glyn Wainwright; Luca Mascitelli; Mark R. Goldstein

eISSN: 1896-9151
ISSN: 1734-1922

Archives of Medical Science

Current issue Archive Special issues Abstracting and indexing Subscription

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2009
vol. 5

Send email

Copy url:

abstract:

Review paper
Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes?

Glyn Wainwright

,

Luca Mascitelli

,

Mark R. Goldstein

Arch Med Sci 2009; 5, 3: 289-295

Online publish date: 2009/10/22

View full text Get citation

Current guidelines encourage ambitious long term cholesterol lowering with statins, in order to decrease cardiovascular disease events. However, by regulating the biosynthesis of cholesterol we potentially change the form and function of every cell membrane from the head to the toe. As research into cell morphology and membrane function realises more dependencies upon cholesterol rich lipid membranes, our clinical understanding of long term inhibition of cholesterol biosynthesis is also changing. This review of non-cardiovascular research concerning such membrane effects raises important new issues concerning the clinical advantages and disadvantages of the long term use, and broadening criteria, of cholesterol reductions.

keywords:

Review paperCholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes?

Glyn Wainwright , Luca Mascitelli , Mark R. Goldstein

cholesterol, exocytosis, lipid, membrane, statin

Review paper
Cholesterol-lowering therapy and cell membranes. Stable plaque at the expense of unstable membranes?

Glyn Wainwright

,

Luca Mascitelli

,

Mark R. Goldstein